Stockscreener 앱 받기
120.38
1.17%
-1.43
전일 마감가:
$121.81
열려 있는:
$121.47
하루 거래량:
542.17K
Relative Volume:
1.04
시가총액:
$7.65B
수익:
$3.87B
순이익/손실:
$386.60M
주가수익비율:
20.62
EPS:
5.8371
순현금흐름:
$323.86M
1주 성능:
+0.39%
1개월 성능:
-1.42%
6개월 성능:
-8.39%
1년 성능:
-7.83%
1일 변동 폭
$119.50
$121.52
1주일 범위
$118.78
$122.42
52주 변동 폭
$103.23
$146.91
Aptargroup Inc Stock (ATR) Company Profile
명칭
Aptargroup Inc
전화
(815) 477-0424
주소
265 EXCHANGE DRIVE, CRYSTAL LAKE, IL
Compare ATR vs ISRG, BDX, RMD, MDLN, ALC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ATR
Aptargroup Inc
|
120.38 | 7.65B | 3.87B | 386.60M | 323.86M | 5.8371 |
ISRG
Intuitive Surgical Inc
|
423.96 | 149.78B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
183.75 | 50.05B | 21.37B | 1.41B | 3.07B | 3.9437 |
RMD
Resmed Inc
|
230.05 | 32.35B | 5.54B | 1.52B | 1.74B | 10.37 |
MDLN
Medline Inc
|
36.26 | 31.81B | 29.14B | 1.07B | 1.05B | 1.1956 |
ALC
Alcon Inc
|
64.11 | 30.99B | 10.63B | 819.00M | 1.59B | 1.6577 |
Aptargroup Inc Stock (ATR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-10-07 | 개시 | Deutsche Bank | Buy |
| 2026-07-14 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2026-03-20 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2026-01-06 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2025-11-03 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2025-09-04 | 개시 | KeyBanc Capital Markets | Overweight |
| 2025-01-07 | 개시 | Raymond James | Outperform |
| 2025-01-06 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2024-10-14 | 업그레이드 | Jefferies | Hold → Buy |
| 2024-04-29 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2024-01-03 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2021-08-02 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2021-04-14 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2020-10-14 | 개시 | Seaport Global Securities | Neutral |
| 2020-04-27 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2020-03-25 | 업그레이드 | BMO Capital Markets | Market Perform → Outperform |
| 2020-03-04 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2020-02-26 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2019-07-08 | 개시 | Morgan Stanley | Overweight |
| 2019-04-05 | 재확인 | BofA/Merrill | Underperform |
| 2019-02-27 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2018-05-18 | 개시 | Jefferies | Hold |
| 2016-12-07 | 다운그레이드 | BofA/Merrill | Buy → Underperform |
| 2016-10-13 | 개시 | Jefferies | Hold |
| 2016-01-05 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2015-11-02 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2015-09-15 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2015-05-01 | 업그레이드 | BofA/Merrill | Underperform → Neutral |
| 2013-02-19 | 재확인 | Deutsche Bank | Hold |
| 2013-01-08 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2012-07-10 | 다운그레이드 | KeyBanc Capital Mkts | Buy → Hold |
| 2012-04-11 | 개시 | KeyBanc Capital Mkts | Buy |
| 2011-06-13 | 업그레이드 | KeyBanc Capital Mkts | Hold → Buy |
모두보기
Aptargroup Inc 주식(ATR)의 최신 뉴스
US038336AA11 Bond Yield and Price — BONDSCOM:US038336AA11 - TradingView
AptarGroup, Inc. (ATR) Stock Forecasts - Yahoo Finance
AptarGroup stock gets Deutsche Bank Buy rating at USD 150 - AD HOC NEWS
AptarGroup, Inc. (ATR) Stock Forecasts - Yahoo Finance
What Makes AptarGroup (NYSE:ATR) Stand Out in Russell 1000? - Kalkine Media
AptarGroup stock heads into October 29 earnings after Q2 growth - AD HOC NEWS
US038336AB93 Bond Yield and Price — BONDSCOM:US038336AB93 - TradingView
AptarGroup (ATR) Loses 5.9% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Zacks Investment Research
AptarGroup (ATR) Loses 5.9% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Yahoo Finance
AptarGroup, Inc. (ATR) Stock forecasts - Yahoo Finance UK
AptarGroup, Inc. (ATR) Stock Forecasts - Yahoo Finance
ATR5372867 Bond Profile: Coupon and Redemption - TradingView
APTARGROUP INC. R (AGT.MU) Q2 FY2026 earnings call transcript - Yahoo Finance
Zacks Research Estimates AptarGroup's Q3 Earnings (NYSE:ATR) - MarketBeat
Confluence Investment Management LLC Sells 16,696 Shares of AptarGroup, Inc. $ATR - MarketBeat
AptarGroup, Inc. (ATR) Stock Forecasts - Yahoo Finance
AptarGroup, Inc. (ATR) Stock Price, News, Quote & History - Yahoo! Finance Canada
Zacks Research Forecasts AptarGroup's Q3 Earnings (NYSE:ATR) - MarketBeat
ETFs Investing in AptarGroup, Inc. Stocks - TradingView
AptarGroup, Inc. (ATR) stock price, news, quote and history - Yahoo Finance Australia
Zacks Industry Outlook Highlights Avery Dennison, AptarGroup and Karat Packaging - finance.yahoo.com
AptarGroup's Bottom Line Pressures Are Preventing An Upgrade (NYSE:ATR) - Seeking Alpha
AptarGroup, Inc. (ATR) stock price, news, quote and history - Yahoo Finance Singapore
AptarGroup, Inc. (ATR) Stock Forecasts - Yahoo! Finance Canada
AptarGroup, Inc. (ATR) Stock Forecasts - finance.yahoo.com
AptarGroup, Inc. (NYSE:ATR) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
AptarGroup Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
AptarGroup (ATR) Could Be 20% Undervalued On MGH Research Partnership - Yahoo Finance
Russian decree affects small AptarGroup (NYSE: ATR) unit - Stock Titan
Aptar Pharma and Massachusetts General Hospital Collaborate on Platform to Establish Predictive, Data-Driven Model for Advancing Nose-to-Brain Drug Delivery - Aptar
Aptar Pharma Expands Preservative Free Technology Production in Latin America - Voice of Alexandria
Aptar Pharma Expands Preservative Free Technology Production in Latin America - Business Wire
AptarGroup (ATR) Stock Price, News & Analysis $ATR - MarketBeat
Aditya J. Gandhi resigns as AptarGroup chief accounting officer; Daniel Ackerman named interim - TradingView
AptarGroup (ATR) names interim accounting chief after Gandhi exit - Stock Titan
Aptargroup, Inc. Announces Management Changes, Effective from September 11, 2026 - marketscreener.com
Aceso Therapeutics advances ACT-101 with Aptar collaboration - BioWorld News
Aptar and Aceso Therapeutics Announce Collaboration to Advance Inhaled Antisense Oligonucleotide Therapy for Cystic Fibrosis - BioSpace
Aptar and Aceso Therapeutics Announce Collaboration to Advance Inhaled Antisense Oligonucleotide Therapy for Cystic Fibrosis - 巴士的報
Aptar and Aceso Therapeutics Announce Collaboration to Advance Inhaled Antisense Oligonucleotide Therapy for Cystic Fibrosis - Business Wire
AptarGroup, Inc. (ATR) Stock Analysis: A 33.54% Potential Upside Beckons Investors - DirectorsTalk Interviews
Aptargroup Stock Price Forecast. Should You Buy ATR? - StockInvest.us
Aptargroup CHRO Shiela Vinczeller sells $99,732 in company stock By Investing.com - Investing.com South Africa
Aptargroup CHRO Shiela Vinczeller sells $99,732 in company stock By Investing.com - Investing.com Australia
AptarGroup (ATR) Chief Human Resources Officer Shiela Vinczeller Sells 765 Shares - GuruFocus
AptarGroup CHRO Shiela Vinczeller Sells 765 Shares of Common Stock at $130.37 Average Price - Kalkine Media
Aptargroup CHRO Shiela Vinczeller sells $99,732 in company stock By Investing.com - Investing.com Australia
Aptargroup CHRO Shiela Vinczeller sells $99,732 in company stock By Investing.com - Investing.com Canada
Aptargroup CHRO Shiela Vinczeller sells $99,732 in company stock - Investing.com India
Aptargroup CHRO Shiela Vinczeller sells $99,732 in company stock - Investing.com
Aptargroup Inc (ATR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Aptargroup Inc 주식 (ATR) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| SHIELA PALLERNE VINCZELLER | Officer |
Sep 02 '26 |
Proposed Sale |
130.37 |
765 |
99,733 |
0 |
| Touya Gael | Segment Pres., CEO Designate |
Aug 27 '26 |
Sale |
133.76 |
3,740 |
500,276 |
29,102 |
| GAEL TOUYA | Officer |
Aug 27 '26 |
Proposed Sale |
133.76 |
3,740 |
500,276 |
0 |
| Prieur Marc | Officer |
Aug 04 '26 |
Proposed Sale |
136.00 |
3,500 |
476,000 |
0 |
| Prieur Marc | Segment President |
Aug 04 '26 |
Sale |
136.26 |
3,500 |
476,897 |
15,823 |
| STEPHAN B TANDA | Director |
Aug 03 '26 |
Proposed Sale |
136.16 |
9,838 |
1,339,588 |
0 |
| Tanda Stephan B. | President and CEO |
Aug 03 '26 |
Option Exercise |
74.79 |
9,838 |
735,784 |
248,567 |
| Tlili Hedi | Segment President |
Aug 03 '26 |
Sale |
135.00 |
8,854 |
1,195,290 |
15,379 |
| Tanda Stephan B. | President and CEO |
Aug 03 '26 |
Sale |
136.16 |
9,838 |
1,339,588 |
238,729 |
| HEDI TLILI | Officer |
Aug 03 '26 |
Proposed Sale |
135.00 |
8,855 |
1,195,425 |
0 |
0.87%
0.45%
자본화:
|
볼륨(24시간):